Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133898) titled 'An Observational Study on the Efficacy and Safety of Aparolidorelimab in the Treatment of Advanced Solid Tumors' on Oct. 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Huai He Hospital of Henan University
Condition:
Advanced solid tumors confirmed by histology or pathology
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-18
Target Sample Size: Ipafricept treatment group:360;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329587
Disclaimer: Curated by HT Syndication....